GordonMD Global Investments LP - Nov 13, 2025 SCHEDULE 13G Report for Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX)

Filing Manager: GordonMD Global Investments LP
Reporting Manager: GordonMD Global Investments LP
Security: Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: KYTX
Shares outstanding: 43.7M shares
Disclosed Ownership: 3.06M shares
Ownership: 7%
Form type: SCHEDULE 13G
Date filed: 11/17/2025, 03:41 PM
Date of event: Nov 13, 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
GordonMD Global Investments LP	7%	3.06M	3.06M	/s/ GordonMD Global Investments GP LLC	Craig D. Gordon / Managing Member of the General Partner
GordonMD Long Biased Master Fund LP	6.2%	2.74M	2.74M	/s/ GordonMD Long Biased GP LLC	GordonMD Long Biased GP LLC / Managing Member of the General Partner
GordonMD Long Biased GP LLC	6.2%	2.74M	2.74M	/s/ Craig D. Gordon	Craig D. Gordon / Managing Member
Craig D. Gordon	7%	3.06M	3.06M	/s/ Craig D. Gordon	Craig D. Gordon
GordonMD Global Investments GP LLC	7%	3.06M	3.06M	/s/ Craig D. Gordon	Craig D. Gordon / Managing Member